Jefferies Group's position in Emergent Biosolutions is currently worth $82.7 Thousand. That's 0.00% of their equity portfolio (1065th largest holding). The first Emergent Biosolutions trade was made in Q2 2023. Since then Jefferies Group bought shares two more times and sold shares on one occasions. The investor's estimated purchase price is $118 Thousand, resulting in a loss of 30%.
Global Influenza Vaccine Market Size study, by Vaccine Type (Quadrivalent, Trivalent), by Type (Seasonal, Pandemic), by Technology (Egg-based, Cell-based), b...
No summary available.
ATX Total Return (incl. dividends) reaches its all-time high Equity turnover in HY1 2021 stable at previous year''s level (EUR 39 billion) Three new entries ...
LONDON , June 28, 2021 /PRNewswire/ -- Slovenská sporitea, the largest commercial bank in Slovakia , has chosen FICO ® Decision Optimizer to increase profita...